1.Resveratrol, diabetes, and obesity
More than one-third of United States adults suffer impairments in glucose metabolism. These impairments include insulin resistance, defects in insulin secretion, impaired insulin receptor signaling, inability to use fat for energy, associated disturbances in lipid profiles, and increased pro-inflammatory cytokines . Resveratrol improves insulin sensitivity, glucose tolerance, and lipid profiles in obese or metabolically abnormal people. Resveratrol has been shown to lower fasting glucose and insulin concentrations, improve HbA1c, increase HDL, and reduce LDL cholesterol and hypertension . Resveratrol was found to improve the activity of metabolic sensors, including SIRT1 and AMP-activated protein kinase
Resveratrol is a phytoalexin, a substance produced by certain plant species at sites of pathogen infestation . It functions by inhibiting the growth of bacteria or fungi, which has raised the question of how resveratrol might affect eukaryotic cell growth and proliferation. Resveratrol has been found to inhibit growth and proliferation in several human cancer cell lines, including breast, colon, liver, pancreatic, prostate, skin, thyroid, white blood cells and lungs . In total, resveratrol has been shown to inhibit the initiation, promotion, and progression of cancer.
Post time: Jul-07-2022
